MRI shows drugs that can prevent heart damage in breast cancer patients

Jodelle Maglaya | | Health Imaging | Diagnostic Imaging

Researchers who led a new landmark clinical trail using carding MRI found that combining heart medication with chemotherapy reduces the risk of heart damage in patients with early-stage breast cancer.

The new five year study at the University of Alberta and Alberta Health Services found that beta blockers and ACE inhibitors, effectively prevent a drop in heart function from cancer treatment.  

The study is funded by the Canadian Institutes of Health Research (CIHR) and Alberta Cancer Foundation.  

Read the full article here:

Drugs prevent heart damage during breast cancer treatment, study show

Jodelle Maglaya

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.